You seem to be using an outdated version of Internet Explorer. Please note that this site does not support this browser version (a href="http://windows.microsoft.com/de-de/windows/end-support-help">as does Microsoft). You may experience design inconsistencies and error messages. We are sorry for any inconveniences.

News

Haniel invests in High-Tech Gründerfonds

1. June 2017
Complementing investments in venture capital funds as part of digital initiative Haniel, a German family-equity company, has invested in High-Tech Gründerfonds III (HTGF III). With HTGF III, up to 40 technology companies are expected to receive financial support with a target fund volume of €300 million per year. In addition to its financial involvement, the fund offers technology companies the More …

BÜFA fosters innovative tech start-ups

Oldenburg-based chemicals company takes stake in High-Tech Gründerfonds “I am delighted that BÜFA GmbH & Co. KG has decided to invest in High-Tech Gründerfonds. With your support, we intend to continue the success enjoyed by High-Tech Gründerfonds, a development that benefits Germany as a hub of business,” German cabinet minister Sigmar Gabriel wrote in an official letter to BÜFA, thanking More …

Dräger acquires majority stake in Hamburg-based start-up bentekk

3. April 2017
Dräger Safety AG & Co. KGaA has acquired a 51 percent stake in bentekk GmbH from seed investors High-Tech Gründerfonds (HTGF) and Innovationsstarter Fonds Hamburg (IFH). This latest acquisition sees Dräger extend its expertise in the area of mobile gas measurement even further. bentekk, based in the south of Hamburg, specializes in developing innovative gas measurement devices for industrial applications. bentekk’s More …

Atriva receives seed financing to develop its next generation influenza therapeutic

7. February 2017
The next generation of Antiviral Therapies: Led by Stichting Participatie Atriva together with High-Tech Gründerfonds (HTGF), Atriva Therapeutics GmbH has received seed financing from Dutch and German private investors to advance Atriva’s antiviral MEK-Inhibitors (Mitogen-activated protein kinase kinase inhibitor) against Influenza into the clinical development stage. Atriva Therapeutics stands for the next generation of antiviral therapies. MEK Inhibitors have high More …

Bio-separation goes digital – Start-up adds some excitement to mechanical separation technology –

30. November 2016
Four investors are financing continued growth by i3 Membrane GmbH. High-Tech Gründerfonds (HTGF) in Bonn, Innovationsstarter Fonds in Hamburg, Mittelständische Beteiligungsgesellschaft Sachsen mbH (MBG) in Dresden and a private US investor are investing a 7-digit Euro sum in further developing and launching new filters and separation technologies. Ultra-thin metal coatings on conventional membranes can be charged with electric current to More …

Rigontec Raises Additional €15M in Extended Series A to Advance Novel RIG-I Targeted Immuno-Oncology Therapeutics

6. September 2016
Rigontec, the leader in RIG-I targeting RNA therapeutics, today announced that it has secured EUR 15 million in a third and final closing of its Series A round. The financing represents additional capital from current investors Boehringer Ingelheim Venture Fund, Forbion Capital Partners, High-Tech Gründerfonds (HTGF), NRW.BANK, MP Healthcare Venture Management, Sunstone Capital and Wellington Partners Life Sciences. The funding More …

High-Tech Gruenderfonds announces profitable exit of portfolio company SOPAT

6. August 2014
SOPAT GmbH was founded in 2012 by Dr. Sebastian Maass, Juergen Rojahn and Joern Emmerich and offers the first fully automated, precise, in situ real-time analysis of particles in chemical processes. Since its foundation in Berlin, SOPAT has achieved strong growth in sales and could win well-known industrial clients. In 2013 High-Tech Gruenderfonds financed the company together with Steelhouse Ventures More …

WPX Faserkeramik: HTGF invests into energy efficiency in metal refining

23. January 2014
The European market volume for industrial heat treatment of metals exceeds EUR 25 bn annually. Conventional kiln furniture for industrial furnaces is typically made of metals or ceramics. This causes significant costs due to energy inefficiency, equipment downtime and wearout, and deficient products. Both metals and ceramics waste a significant share of thermal output due to their heat capacity. Furthermore, More …

evocatal draws two new investors as it closes €3.5m Series B round

24. June 2013
evocatal GmbH has completed a Series B financing round. All of the company’s existing investors took part, along with new investors NRW.BANK and LANXESS. In realizing the next step of its growth strategy, Düsseldorf-based enzyme specialist evocatal has partnered with two new investors: specialty chemicals company LANXESS and the NRW.BANK. The investments from this round of financing will be used More …

High-Tech Gründerfonds and Steelhouse Ventures Limited invest in SOPAT GmbH

4. February 2013
The Berlin high-tech startup SOPAT GmbH is concluding its first round of financing. The investors are High-Tech Gründerfonds (HTGF) and Steelhouse Ventures Limited (SVL). The mission of SOPAT is to revolutionize the measurement of particulate systems. Using the digital analysis of particle images in previously unattainable results, it becomes possible to directly optimize the production in chemical, pharmaceutical, and biotechnological More …